3M said GAAP sales for Q4 rose to $6.1 billion, up 2.1%; operating margin was 13.0%, down 510 basis points; and EPS was $1.07, down 20%, all year on year.

1. 01

   3M said GAAP sales for Q4 rose to $6.1 billion, up 2.1%; operating margin was 13.0%, down 510 basis points; and EPS was $1.07, down 20%, all year on year.

2. 02

   The company said full-year 2025 adjusted sales were $24.3 billion (adjusted organic growth of 2.1%), adjusted operating margin was 23.4% (up 200 basis points), and adjusted EPS was $8.06 (up 10%). It said operating cash flow was $2.3 billion and adjusted free cash flow was $4.4 billion.

3. 03

   3M said it built up GAAP EPS of $1.07 for Q4 by adding net costs for significant litigation of $0.56, manufactured PFAS products of $0.39 and transformation costs of $0.11, and by subtracting the increase in the value of its Solventum ownership of $(0.30), to arrive at adjusted EPS of $1.83.

4. 04

   The company set its full-year 2026 outlook, calling for adjusted sales growth of about 4% (adjusted organic growth of about 3%), adjusted operating margin expansion of 70 basis points to 80 basis points, adjusted EPS of $8.50 to $8.70, and adjusted operating cash flow of $5.6 to $5.8 billion.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.